(株)メドレックスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4586/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/06/17 | 日証協 | 965,200株 | +6.41% | 173,400株 | +56.78% | 818,526株 | -2.89% | 137,170株 | +101.37% |
2016/06/10 | 日証協 | 907,100株 | -0.68% | 110,600株 | -11.52% | 842,866株 | +0.26% | 68,120株 | -27.61% |
2016/06/03 | 日証協 | 913,300株 | +1.7% | 125,000株 | -49.17% | 840,666株 | -0.67% | 94,100株 | -37.27% |
2016/05/27 | 日証協 | 898,000株 | +10.29% | 245,900株 | +267.01% | 846,376株 | +13.12% | 150,010株 | +289.03% |
2016/05/20 | 日証協 | 814,200株 | -2.72% | 67,000株 | -27.41% | 748,206株 | -9.21% | 38,560株 | -62.08% |
2016/05/13 | 日証協 | 837,000株 | +5.68% | 92,300株 | -48.32% | 824,106株 | +6.88% | 101,700株 | +121.57% |
2016/05/06 | 日証協 | 792,000株 | -3.7% | 178,600株 | +110.37% | 771,066株 | -3.12% | 45,900株 | -56.44% |
2016/04/28 | 日証協 | 822,400株 | +28.26% | 84,900株 | -66.67% | 795,936株 | +28.06% | 105,380株 | -41.6% |
2016/04/22 | 日証協 | 641,200株 | +32.42% | 254,700株 | +19.13% | 621,556株 | +22.66% | 180,430株 | +42.88% |
2016/04/15 | 日証協 | 484,200株 | +10.65% | 213,800株 | +310.36% | 506,736株 | +3.06% | 126,280株 | +57.46% |
2016/04/08 | 日証協 | 437,600株 | +9.1% | 52,100株 | +30.25% | 491,706株 | +15.31% | 80,200株 | +151.38% |
2016/04/01 | 日証協 | 401,100株 | +4.92% | 40,000株 | +463.38% | 426,406株 | +5.21% | 31,904株 | +81.27% |
2016/03/25 | 日証協 | 382,300株 | +3.24% | 7,100株 | -54.49% | 405,306株 | +3.68% | 17,600株 | -23.48% |
2016/03/18 | 日証協 | 370,300株 | +1.42% | 15,600株 | -56.18% | 390,906株 | +4.13% | 23,000株 | -17.56% |
2016/03/11 | 日証協 | 365,100株 | +11.11% | 35,600株 | +291.21% | 375,406株 | +4.13% | 27,900株 | +46.84% |
2016/03/04 | 日証協 | 328,600株 | -7.15% | 9,100株 | +35.82% | 360,506株 | +1.38% | 19,000株 | +8.57% |
2016/02/26 | 日証協 | 353,900株 | +0.06% | 6,700株 | -32.32% | 355,606株 | -4.31% | 17,500株 | +246.4% |
2016/02/19 | 日証協 | 353,700株 | -0.31% | 9,900株 | +147.5% | 371,606株 | +0.68% | 5,052株 | +3.1% |
2016/02/12 | 日証協 | 354,800株 | 0% | 4,000株 | 0% | 369,104株 | +0.16% | 4,900株 | +188.24% |
※株式分割は考慮していませんのでご注意ください。
Page Top